Trademarkia Logo

Canada

C$
Trademark Search in Canada
HEALTH, PLANET & OUR COMMITMENT (& DESIGN)
HEALTH, PLANET & OUR COMMITMENT (& DESIGN)
FORMALIZED

on 23 Aug 2024

Last Applicant/ Owned by

FINCHLEY RESEARCH & DEVELOPMENT INC.

6111 Royalmount AvenueSuite 100Montreal

QUEBEC

CA

H4P2T4

Serial Number

2345633 filed on 23rd Aug 2024

Correspondent Address

LAVERY, DE BILLY, LLP

1 Place Ville Marie, Suite 4000Montréal

QUÉBEC

CA

H3B4M4

HEALTH, PLANET & OUR COMMITMENT (& DESIGN)

Trademark usage description

pharmaceutical preparations and substances for the treatment of inner ear diseases, disorders and infections; pharmaceutical preparations for the pre Read More

Vienna Information


5 . 3 . 11

Other leavesAutres feuilles

5 . 3 . 13

Stylized leavesFeuilles stylisées

5 . 3 . 14

One leafUne feuille

26 . 4 . 2

RectanglesRectangles

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 6

Quadrilateral figures with one or more convex or concave sides -- Note: Not including elongated surfaces with one or more convex or concave sides (25.3.1).Figures quadrilatérales à un ou plusieurs côtés convexes ou concaves -- Note: Non compris les surfaces allongées avec un ou plusieurs côtés convexes ou concaves (25.3.1).

26 . 4 . 15

Quadrilaterals containing representations of animals or parts of animals' bodies or plantsQuadrilatères contenant la représentation d'animaux, de parties du corps d'un animal ou de végétaux

26 . 4 . 18

Quadrilaterals containing one or more lettersQuadrilatères contenant une ou plusieurs lettres

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

29 . 1 . 6

White, grey, silverBlanc, gris, argent

29 . 1 . 3

GreenVert

Classification Information


Class [005]
Analgesics; androgen preparations; anti-inflammatories; antiarrhythmic agents; antibacterials; antibiotics; anticoagulants; anticonvulsants; antidepressants; antiemetics; antihistamines; antihypertensives; antineoplastic agents for bladder cancer instillation; antipyretics; antiseptics; antivirals; anxiolytics; corticosteroids; cough syrups; diarrhea medication; diuretics; enema preparations; germicides; human pharmaceuticals for treatment of cancer; laxatives; medicated dental rinses; medicinal hair growth preparations; muscle relaxants; nausea treatment preparations; opioid antagonist pharmaceutical preparations; oral contraceptives; pain relief medication; pharmaceutical anti-allergic preparations and substances; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations for controlling cholesterol; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for maintaining normal blood pressure and heart function; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of iron deficiency and anemia in humans; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the prevention and treatment of pulmonary hypertension and pulmonary arterial hypertension; pharmaceutical preparations for the prevention and treatment of thrombosis; pharmaceutical preparations for the treatment and prevention of hiv infection; pharmaceutical preparations for the treatment and the prevention of dementia; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of asthma; pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis; pharmaceutical preparations for the treatment of dermatitis, eczema and psoriasis; pharmaceutical preparations for the treatment of gastroenterological, intestine, bowel, stomach and digestive disorders; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations for the treatment of hypertension; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of migraine; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations for the treatment of prostate disorders; pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; pharmaceutical preparations for treating high cholesterol; pharmaceuticals for the treatment of bone diseases; pharmaceuticals for the treatment of erectile dysfunction; potassium preparations for pharmaceutical purposes; sedatives; stool softeners; thyroid and parathyroid hormone preparations; tumor suppressing agents


Classification kind code

12

Mark Details


Serial Number

2345633

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 48
on 31st Mar 2025
Agent Changed
Submitted for opposition 287
on 5th Sept 2024
Pre-Assessment Letter Sent
Submitted for opposition 30
on 23rd Aug 2024
Filed
Submitted for opposition 1
on 23rd Aug 2024
Created
Submitted for opposition 31
on 23rd Aug 2024
Formalized